Log in

8225 China Health Group Inc. HKEX · China

China Health Group (8225) news

China Health Group Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 8225, recorded under China. The directory classifies it as Mixed biopharma / other operations. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest China Health Group news

We have not published a story on China Health Group yet. When there is news, it will appear here.

Questions about China Health Group

What is the ticker symbol of China Health Group?

China Health Group Inc. trades under the ticker 8225 on HKEX.

Where is China Health Group listed?

China Health Group Inc. is listed on HKEX.

Which country or territory is China Health Group listed under?

Our directory records China Health Group Inc. under China.

What does China Health Group do?

Our directory classifies China Health Group Inc. as: Mixed biopharma / other operations. This is a directory classification, not a description of the pipeline.

What is the ISIN of China Health Group?

The ISIN recorded for China Health Group Inc. is KYG2117N1088.

Does aibio.space cover China Health Group?

aibio.space lists China Health Group Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to China Health Group?

Companies in our directory listed in the same country and business area as China Health Group: New Journey Health Technology Group Co., Ltd.Class A, Zhejiang NHU Co., Beijing Sun-Novo Pharmaceutical Research Co., Bon Natural Life, Hansoh Pharmaceutical Group Company, Zhejiang Jingxin Pharmaceutical Co..

Investor discussion: China Health Group

Members talk about China Health Group (8225). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at China Health Group, newest first. Each line links the filing it comes from.

  1. Financings

    Share or debt issue: (1) PROPOSED GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, (2) RE-ELECTION OF RETIRING DIRECTORS, (3) PROPOSED AMENDMENT TO THE ARTICLES OF ASSOCIATION AND ADOPTION OF THE THIRD AMENDEDAND RESTATED ARTICLES OF ASSOCIATION AND (4) NOTICE OF ANNUAL GENERAL MEETING. Source

  2. Legal

    Legal proceedings: Announcement Regarding the Outcome of Arbitration on a Historical Contract Dispute and Its Impact on Financial Reports. Source

  3. Financings

    Share or debt issue: (1) PROPOSED GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, (2) RE-ELECTION OF RETIRING DIRECTORS, AND (3) NOTICE OF ANNUAL GENERAL MEETING. Source

Press releases

Headlines of China Health Group's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    INSIDE INFORMATION- UPDATE ON ARBITRATION AWARD

  2. HKEXnews

    VOLUNTARY ANNOUNCEMENT REGARDING PROGRESS IN THE RECOVERY OF TRADE RECEIVABLE BY CHINA HEALTH GROUP INC.

  3. HKEXnews

    ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026

  4. HKEXnews

    RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE OF CHAIRMAN OF THE NOMINATION COMMITTEE

  5. HKEXnews

    THIRD AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION

  6. HKEXnews

    POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 17 JULY 2026

  7. HKEXnews

    CLARIFICATION ANNOUNCEMENT- REVISION OF PROXY FORM

  8. HKEXnews

    (1) PROPOSED GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, (2) RE-ELECTION OF RETIRING DIRECTORS, (3) PROPOSED AMENDMENT TO THE ARTICLES OF ASSOCIATION AND ADOPTION OF THE THIRD AMENDEDAND RESTATED ARTICLES OF ASSOCIATION AND (4) NOTICE OF ANNUAL GENERAL MEETING

  9. HKEXnews

    NOTICE OF ANNUAL GENERAL MEETING

  10. HKEXnews

    PROXY FORM FOR ANNUAL GENERAL MEETING

  11. HKEXnews

    PROPOSED AMENDMENT TO THE ARTICLES OF ASSOCIATION

  12. HKEXnews

    PROPOSED ADOPTION OF NEW SHARE OPTION SCHEME

  13. HKEXnews

    INSIDE INFORMATION - DELAY IN CONVENING ANNUAL GENERAL MEETING AND EXPECTED TIMELINE

  14. HKEXnews

    SUPPLEMENTAL ANNOUNCEMENT DISCLOSURES RELATING TO SHARE OPTION SCHEME AND CONTINUING CONNECTED TRANSACTION

  15. HKEXnews

    VOLUNTARY ANNOUNCEMENT REGARDING PROGRESS IN THE RECOVERY OF TRADE RECEIVABLE BY CHINA HEALTH GROUP INC

  16. HKEXnews

    Voluntary Announcement - Supplementary Information Regarding the 2025 Annual Results and Future Development Strategy

  17. HKEXnews

    ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025

  18. HKEXnews

    Announcement Regarding the Outcome of Arbitration on a Historical Contract Dispute and Its Impact on Financial Reports

  19. HKEXnews

    SUPPLEMENTAL ANNOUNCEMENT THE EXPECTED DATE OF DISTRIBUTION OF THE CONTINUING CONNECTED TRANSACTIONS BY CIRCULAR

  20. HKEXnews

    (1)CONTINUING CONNECTED TRANSACTIONS:NEW FRAMEWORK SERVICE AGREEMENT;AND(2)APPOINTMENT OF INDEPENDENT FINANCIAL ADVISER

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:8225 on TradingView.

Listing details

China Health Group Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 8225, recorded under China. The directory classifies it as Mixed biopharma / other operations. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
China Health Group Inc.
Ticker
8225
Listing
HKEX
Country or territory
China
Business scope
Mixed biopharma / other operations
ISIN
KYG2117N1088
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.